| 摘要 |
This invention relates to a compound of general formula (I): wherein A, B, R<SUP>1</SUP>, R<SUP>2 </SUP>and X are as defined in the specification, and pharmaceutical compositions prepared from the same, in combination with one or more NS5B polymerase inhibitors, for use in treatment of hepatitis C virus.
|
